Biotage and MIP Technologies have announced that the owners of the two companies have reached an agreement that will see Biotage will acquire all outstanding shares in MIP Technologies and assume ownership of the company.
Biotage and MIP Technologies have announced that the owners of the two companies have reached an agreement that will see Biotage acquire all outstanding shares in MIP Technologies and assume ownership of the company.
“This is an excellent strategic fit regarding Biotage’s expansion and diversification into markets outside of pharma and it will certainly fuel our efforts within sample preparation. One of our ambitions going forward is to further develop our sample preparation business and to drive our consumables sales to get a more even balance between the sale of instruments and consumables,” says Torben Jörgensen, Biotage’s president and CEO in a statement.
MIP Technologies is located in Lund, Sweden and develops solutions for the separations field using proprietary molecularly imprinted polymer (MIP) technology and other novel polymer chemistries.
According to the company, its customers include several multi-national blue chip customers in the food and beverage industries. The company also develops front line analytical products for food, environmental, veterinary and pharmaceutical laboratories.
For more information visit www.biotage.com